This inventor holds 1 USPTO granted patent. Top assignee: Abdera Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Emma Jane Cummins: Innovator in Biopharmaceuticals
Introduction
Emma Jane Cummins is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative research and development efforts. With a focus on binding polypeptides, her work has the potential to impact various therapeutic applications.
Latest Patents
Emma holds a patent for "5T4 BINDING POLYPEPTIDES AND USES THEREOF." This patent highlights her expertise in creating polypeptides that can be utilized in medical treatments, showcasing her role as a key player in advancing biopharmaceutical technologies. She has 1 patent to her name, reflecting her commitment to innovation in her field.
Career Highlights
Emma is currently employed at Abdera Therapeutics Inc., where she continues to push the boundaries of biopharmaceutical research. Her work at the company emphasizes the importance of developing new therapeutic strategies that can address unmet medical needs.
Collaborations
Emma collaborates with notable colleagues, including Alexander Laurence Mandel and Raja Solomon Viswas. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in the biopharmaceutical sector.
Conclusion
Emma Jane Cummins exemplifies the spirit of innovation in the biopharmaceutical industry. Her contributions through patents and collaborations are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile